recent
polyomavirus
ki
wu
identifi
airway
patient
acut
respiratori
symptom
epidemiolog
pathogenesi
two
virus
fulli
understood
develop
molecular
assay
real
time
pcr
use
examin
biolog
role
differ
clinic
syndrom
evalu
differ
target
region
amplif
polyomavirus
ki
wu
compar
publish
primerprob
set
set
design
laboratori
describ
use
test
clinic
specimen
stool
tonsil
result
show
laboratori
design
sensit
detect
polyomavirus
ki
wu
dna
clinic
sampl
choic
primerprob
set
primarili
region
amplif
may
relev
understand
pathogen
role
virus
polyomavirus
ki
wu
polyomavirida
famili
constitut
small
doublestrand
dna
virus
widespread
human
popul
seropreval
adult
two
polyomavirus
known
infect
human
jc
viru
jcv
bk
viru
bkv
discov
gardner
et
al
padgett
et
al
anoth
polyomaviru
infect
natur
rhesu
monkey
introduc
accident
human
popul
contamin
earli
use
poliomyel
vaccin
butel
lednicki
bergallo
et
al
follow
primari
infect
occur
usual
respiratori
tract
often
asymptomat
polyomavirus
establish
latenc
urinari
tract
brain
b
cell
jiang
et
al
reactiv
frequent
immunocompromis
patient
transplant
recipi
sever
consequ
costa
et
al
two
novel
polyomavirus
describ
recent
name
karolinska
institutet
viru
kiv
washington
univers
viru
wuv
alland
et
al
gaynor
et
al
kiv
wuv
isol
first
respiratori
secret
human
patient
acut
respiratori
tract
symptom
case
kiv
also
faecal
sampl
alland
et
al
gaynor
et
al
babakirmina
et
al
jiang
et
al
wuv
share
ident
bkv
jcv
similar
kiv
kiv
wuv
nonstructur
protein
display
amino
acid
sequenc
similar
primat
polyomavirus
structur
protein
exhibit
low
degre
similar
known
polyomavirus
suggest
wuv
kiv
defin
novel
branch
within
polyomavirida
famili
unexplor
biolog
controversi
clinic
signific
alland
et
al
gaynor
et
al
norja
et
al
develop
molecular
assay
real
time
pcr
kiv
wuv
detect
could
use
determin
epidemiolog
pathogenesi
pathogen
role
two
virus
differ
clinic
syndrom
real
time
pcr
protocol
design
differ
paramet
target
region
condit
amplif
consid
order
obtain
enhanc
sensit
specif
highthroughput
routin
laboratori
use
inhous
protocol
requir
optim
standard
valid
process
consist
assess
sensit
specif
effici
precis
linear
furthermor
choic
sampl
materi
also
refer
matrix
could
strong
influenc
result
consid
valid
process
dimech
et
al
rabenau
et
al
aim
studi
evalu
differ
target
region
amplif
kiv
wuv
compar
publish
primerprob
set
set
design
laboratori
differ
clinic
specimen
optim
quantit
assay
use
suitabl
primerprob
set
total
clinic
specimen
stool
tonsil
provid
mediterranean
hematolog
institut
rome
cytodiagnost
histopatholog
unit
maggior
hospit
triest
respect
studi
twentyf
milligram
paraffinembed
tonsillar
tissu
deparaffin
xylen
ethanol
digest
subsequ
overnight
c
proteinas
k
case
faecal
sampl
mg
stool
extract
total
dna
extract
carri
use
qiaamp
dna
mini
kit
qiagen
milan
itali
accord
manufactur
specif
follow
target
region
evalu
kiv
regulatori
region
primerprob
set
kia
small
antigen
kib
describ
previous
bialasiewicz
et
al
gene
laboratori
design
primerprob
set
kic
wuv
regulatori
region
wua
wuc
larg
antigen
wub
describ
previous
bialasiewicz
et
al
gene
laboratori
design
primerprob
set
wud
tabl
laboratori
design
real
time
pcr
primer
taqman
probe
perform
use
primer
express
softwar
appli
biosystem
cheshir
uk
reaction
mixtur
contain
master
mix
platinum
qpcr
supermixudg
rox
invitrogen
mm
primer
mm
vic
probe
housekeep
gene
gapdh
intern
control
five
microlit
dna
ad
l
reaction
mix
give
final
reaction
volum
l
amplif
profil
optim
real
time
pcr
system
appli
biosystem
follow
one
cycl
decontamin
c
min
one
cycl
denatur
c
min
follow
cycl
amplif
c
c
cycl
number
fluoresc
signal
background
ct
proport
initi
log
concentr
target
dna
standard
plasmid
construct
optim
standard
valid
inhous
real
time
pcr
assay
standard
plasmid
construct
primer
extern
kic
wud
use
tabl
plasmid
obtain
use
pgemteasi
vector
system
promega
itali
real
time
pcr
quantif
standard
curv
creat
rang
serial
dilut
kiv
wuv
standard
plasmid
quantit
determin
basi
spectrophotometr
analysi
nm
two
laboratori
design
real
time
pcr
assay
kic
wud
optim
test
differ
concentr
target
primer
probe
mm
primerprob
sensit
real
time
pcr
assay
defin
lowest
concentr
target
quantifi
frequenc
dynam
rang
defin
rang
dilut
linear
regress
curv
construct
evalu
use
dilut
copiesreact
kiv
wuv
plasmid
ct
valu
outsid
measur
compris
within
dynam
rang
quantifi
ct
con
tabl
primerprob
set
real
time
pcr
sequenc
sider
neg
precis
intraand
interassay
variabl
cv
evalu
use
differ
concentr
standard
plasmid
rang
copiesreact
within
singl
run
n
differ
run
experi
n
effici
valu
defin
rang
usual
evalu
order
ascertain
abil
detect
target
cycl
sequenc
perform
pcr
amplif
product
use
templat
dna
sequenc
use
bigdy
termin
chemistri
follow
manufactur
instruct
bigdy
termin
cycl
sequenc
kit
appli
biosystem
warrington
uk
subsequ
nucleotid
sequenc
align
perform
use
clustalx
softwar
vitro
specif
two
laboratori
design
real
time
follow
formula
use
quantit
kivand
wuvdna
ng
sampl
quantiti
indic
pcr
softwar
amplif
volum
spectrophotomet
read
precaut
must
taken
prevent
contamin
reaction
tube
product
previous
amplifi
target
dna
specimen
control
prepar
reagent
process
sampl
carri
safeti
cabinet
locat
separ
laboratori
distant
area
amplifi
product
analyz
cabinet
equip
independ
batch
reagent
micropipett
set
steril
reagent
tube
filter
pipett
tip
uracildna
glycosylas
use
elimin
pcr
carryov
contamin
previou
pcr
total
stool
sampl
tonsil
test
determin
sensit
real
time
pcr
assay
result
summar
tabl
consid
stool
specimen
kiv
found
posit
kia
kib
kic
respect
wuv
posit
wua
wub
wuc
wud
respect
case
tonsil
specimen
kiv
posit
none
kia
kib
kic
respect
wuv
found
none
wua
wub
wuc
wud
respect
follow
primerprob
concentr
chosen
mm
kiv
wuv
respect
dynam
rang
two
laboratori
design
real
time
pcr
evalu
carri
triplic
serial
dilut
standard
plasmid
copiesreact
follow
kiv
fig
wuv
fig
sensit
assay
evalu
triplic
result
kiv
wuv
respect
precis
defin
level
concord
individu
test
result
within
singl
round
intraassay
variabl
differ
experi
interassay
variabl
evalu
use
differ
concentr
plasmid
standard
rang
copiesreact
report
tabl
effici
valu
kiv
wuv
respect
individu
assay
compar
respect
perform
duplex
gapdh
differ
term
ct
record
sensit
assay
determin
lowest
standard
dilut
detect
consist
triplic
frequenc
tabl
preval
kiv
wuv
differ
pcr
assay
evalu
studi
found
copiesreact
kiv
wuv
respect
cycl
sequenc
show
two
pcr
assay
complet
homolog
eight
kiv
isol
wuv
isol
describ
date
wwwncbinlmnihgov
web
site
search
perform
march
forward
primer
wuv
recogn
sequenc
wuwuerzburg
genbank
access
no
due
presenc
puntiform
mutat
nucleotid
signific
homolog
sequenc
found
posit
result
demonstr
viral
microbi
strain
indic
molecular
assay
specif
kiv
wuv
primer
probe
test
silico
possibl
crossreact
human
sequenc
unrel
viral
microbi
sequenc
base
data
avail
blast
align
softwar
http
blastncbinlmnihgovblastcgi
viral
load
determin
base
standard
curv
two
laboratori
design
real
time
pcr
result
follow
faecal
sampl
averag
load
genom
ng
extract
dna
median
median
kiv
wuv
respect
viral
load
quantif
tonsil
specimen
possibl
due
ct
valu
behind
linear
rang
ie
ct
valu
correspond
copiesreact
kiv
wuv
respect
current
presenc
new
polyomavirus
ki
wu
investig
extens
alland
et
al
gaynor
et
al
norja
et
al
payungporn
et
al
jiang
et
al
lindau
et
al
thu
avail
optim
clinic
valid
real
time
pcr
assay
could
use
investig
epidemiolog
clinic
impact
virus
well
tissu
tropism
real
time
pcr
assay
describ
close
system
sinc
postamplif
manipul
amplicon
requir
advantag
system
comparison
convent
pcr
includ
reduc
turnaround
time
minimis
potenti
carryov
contamin
abil
scrutinis
close
assay
perform
thu
repres
suitabl
tool
routin
diagnosi
virolog
real
time
pcr
offer
signific
improv
viral
load
quantit
wide
dynam
rang
accommod
least
eight
log
copi
nucleic
acid
templat
made
possibl
data
chosen
linear
phase
amplif
condit
optim
rather
endpoint
final
amount
amplicon
may
affect
inhibitor
poorli
optim
reaction
condit
satur
inhibitori
pcr
byproduct
doublestrand
amplicon
regard
real
time
pcr
design
primerprob
set
although
rel
simpl
comput
point
view
take
account
sever
factor
especi
choic
target
region
studi
assess
two
laboratori
design
real
time
pcr
taqman
assay
detect
polyomavirus
ki
wu
target
gene
respect
describ
method
compar
describ
previous
bialasiewicz
et
al
target
differ
region
light
potenti
impact
choic
detect
kivand
wuvdna
interpret
preval
result
differ
clinic
syndrom
consid
detect
rate
kiv
wuv
clinic
sampl
use
differ
assay
primerprob
set
design
studi
appear
sensit
comparison
publish
could
attribut
choic
target
region
among
faecal
specimen
posit
kic
assay
posit
kia
kib
respect
tonsil
sampl
posit
kic
posit
kib
none
kia
howev
kib
exhibit
lower
ct
valu
comparison
kic
despit
highthroughput
diagnost
laboratori
essenti
enhanc
assay
make
suitabl
use
wide
rang
matric
regard
kic
seem
reliabl
detect
kiv
two
matric
analyz
consid
wud
assay
appear
superior
assay
addit
stool
tonsil
specimen
found
posit
epidemiolog
clinic
impact
new
virus
still
elus
avail
highli
sensit
specif
method
mandatori
obtain
reliabl
relev
data
assess
pcr
assay
viru
detect
base
knowledg
repres
number
genom
sequenc
allow
primerprob
set
design
present
complet
genom
sequenc
eight
clinic
isol
kiv
wuv
respect
known
larger
number
partial
gene
sequenc
character
assay
develop
studi
show
complet
sequenc
homolog
kiv
wuv
isol
due
presenc
puntiform
mutat
target
region
choic
region
instead
larg
use
commonli
human
polyomavirus
consid
unavoid
diagnost
laboratori
work
bkv
jcv
therefor
comparison
method
target
differ
genom
region
repres
use
tool
avoid
falseneg
find
fig
wuv
wud
dynam
rang
copiesreact
r
optim
two
laboratori
design
real
time
pcr
allow
identif
amplif
condit
suitabl
term
primerprob
concentr
effici
linear
sensit
specif
precis
conclus
develop
two
laboratori
design
real
time
pcr
taqman
assay
quantit
detect
polyomavirus
ki
wu
optim
standard
assay
use
differ
clinic
sampl
particular
stool
tonsil
describ
among
variou
paramet
consid
develop
real
time
pcr
assay
choic
primerprob
set
primarili
region
amplifi
could
repres
use
tool
understand
pathogen
role
virus
kiv
wuv
work
support
research
grant
region
piemont
ricerca
sanitaria
finalizzata
cristina
costa
